Andere Kunden interessierten sich auch für
![The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines]( "The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines")
The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines15,99 €![Phake]( "Phake")
Phake41,99 €![Transcultural Artificial Intelligence and Robotics in Health and Social Care]( "Transcultural Artificial Intelligence and Robotics in Health and Social Care")
Transcultural Artificial Intelligence and Robotics in Health and Social Care131,99 €![How To Develop Drug Products]( "How To Develop Drug Products")
How To Develop Drug Products37,99 €![Biotech Regulation for Food Security]( "Biotech Regulation for Food Security")
Biotech Regulation for Food Security29,99 €![Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2024]( "Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2024")
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2024443,99 €![The Antidote]( "The Antidote")
The Antidote17,99 €
A practical guide for those in pharmaceutical companies considering a reclassification (switch) project including Rx to OTC, POM to P, and P to GSL. The book covers past UK switches with key learning and a framework for initiating, setting up and running switch projects within companies. Plus case studies, insight and practical experience to help companies manage and implement successful switch projects.